O
Owkin
Collaborative research platform and unique AI drug development solutions that make precision medicine a reality
Open roles
Owkin in the Paris ecosystem
The Owkin office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
- NCNJF Capital
- SFShana Fisher
- JCJean-Paul Clozel
- NJNicole Junkermann
Series A10 investors entered at this stage
F-Prime
Eight Roads Ventures
Bpifrance
Mubadala Capital
Plug and Play
GV- OCOtium Capital
Frst Capital- CICathay Innovation
- MAMACSF
Series B and later14 investors entered at this stage
- BSBristol-Myers Squibb
- CICNRS Innovation
- SISISTAFUND
- ININRIA
- OVOTB Ventures
- SASanofi
- GAGoogle for Startups Accelerator
- ACAlpha Intelligence Capital
- ÉUÉcole normale supérieure – PSL University
- SESerena
- FCFrench National Centre for Scientific Research - CNRS
- EHEIT Health
- KAKarista
- PUPSL University
Source: Dealroom Talent Intelligence.
Alumni founders
Former Owkin employees who went on to found companies, sorted by Dealroom signal score.
BIBioptimusEst. 2023
David CahanéFrance
RARaidiumEst. 2022
Paul HerentFrance
CAComand AIEst. 2023
Pierre CourtiolFrance
CUCURE51Est. 2022
Simon IstolainenFrance
ENEntalpicEst. 2024
Mathieu GaltierFrancePatents
9 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Owkin was the backer or acquirer, 2023–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Owkin's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Owkin's portfolio, mapped.
See Owkin on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
Devia exits stealth with agentic AI and a new leadership team for pharma quality
Owkin alum's rivercell raises $25M seed for human-cell world model
Norbert Health raises $14M to give nursing robots clinical skills